You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 5,616,582


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,616,582
Title: Quinazoline derivatives as anti-proliferative agents
Abstract:The invention concerns quinazoline derivatives of the formula I ##STR1## wherein m is 1, 2 or 3 and each R.sup.1 includes hydroxy, amino, carboxy, carbamoyl, ureido, (1-4C)alkoxycarbonyl, N-(1-4C)alkylcarbamoyl, N,N-di-[(1-4C)alkyl]carbamoyl, hydroxyamino, (1-4C)alkoxyamino, (2-4C)alkanoyloxyamino, trifluoromethoxy, (1-4C)alkyl, (1-4C)alkoxy and (1-3C)alkylenedioxy; n is 1 or 2 and each R.sup.2 includes hydrogen, hydroxy, halogeno, trifluoromethyl, amino, nitro, cyano and (1-4C)alkyl; or a pharmaceutically-acceptable salt thereof; processes for their preparation; pharmaceutical compositions containing them; and the use of the receptor tyrosine kinase inhibitory properties of the compounds in the treatment of cancer.
Inventor(s): Barker; Andrew J. (Macclesfield, GB2)
Assignee: Zeneca Limited (London, GB)
Application Number:08/490,666
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,616,582

Introduction

United States Patent 5,616,582, issued on April 1, 1997, is a significant patent that has contributed to various technological advancements. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The patent in question, US 5,616,582, is titled and describes a specific invention, but the exact details of the invention are not provided in the sources. However, we can infer several key points from general patent practices and the context of similar patents.

Claim Scope

Importance of Claim Scope

The claim scope is a critical aspect of any patent application. It defines the boundaries of what is protected under the patent. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate due to the abstract idea exception and failure to meet the written description requirement[3].

Specifics of US 5,616,582 Claims

While the specific claims of US 5,616,582 are not detailed in the provided sources, it is essential to understand that claims must be anchored to the embodiments disclosed in the specification. The claims should be specific enough to cover the invention but not so broad that they risk being invalidated. For example, claims that are directed to specific means or methods are often more robust than overly broad claims[3].

Types of Claims

Product Claims

Product claims directly relate to the physical or chemical composition of the invention. These claims are crucial for defining what the patented product is and what distinguishes it from prior art.

Method Claims

Method claims cover the processes or methods used to make or use the invention. These are important for protecting the unique ways in which the invention is utilized or manufactured.

Example from Similar Patents

For instance, in the case of U.S. Patent RE42,353, the claims include both product and method claims. The product claims (claims 1-7, 13-20, and 22) encompass the approved product, while method claims cover the use and manufacturing processes[1].

Patent Landscape

Prior Art and Search Tools

Understanding the prior art is vital when analyzing the scope and claims of a patent. Tools like the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are essential for conducting thorough patent searches. These tools help identify existing patents and published patent applications that could affect the validity and scope of the claims[4].

Global Dossier and Common Citation Document (CCD)

The Global Dossier and CCD are particularly useful for seeing the patent family for a specific application and accessing citation data from multiple IP offices. This helps in understanding how different offices have treated similar inventions and can inform the drafting of claims to avoid prior art issues[4].

Legal Framework and Court Decisions

Abstract Idea Exception

The abstract idea exception, as established by the Supreme Court's Alice decision, is a significant consideration when drafting claims. Claims that are too broad and merely invoke generic processes or machinery rather than specific means or methods risk being invalidated as abstract ideas[3].

Recent Court Decisions

Cases like Yu v. Apple Inc. and Minerva Surgical, Inc. v. Hologic, Inc. highlight the importance of careful claim drafting. These decisions illustrate how overly broad claims can lead to invalidation and emphasize the need for claims to be grounded in specific embodiments and improvements to the relevant technology[3].

Practical Considerations

Budget and Technical Field

The claim scope must be tailored to the client’s budget and the technical field of the invention. In fields with extensive prior art, broader claims are more challenging to get granted and maintain[3].

Client’s Goals

Understanding the client’s goals and the intended use of the patent is crucial. Claims should be directed to achieve the desired level of protection while avoiding unnecessary breadth that could lead to invalidation.

Illustrative Statistics and Examples

  • Patent Validity: According to various studies, patents with overly broad claims have a higher likelihood of being invalidated. For instance, a study by the USPTO found that patents with broader claims are more frequently challenged in post-grant proceedings[4].

  • Cost Implications: The cost of obtaining and maintaining a patent with broad claims is typically higher due to the increased complexity and the need for more extensive prior art searches[3].

Quotes from Industry Experts

  • "While a broad patent claim offers broader protection, a broad claim is not only more difficult to get granted but also easier to get invalidated." - Rimon Law[3].

  • "Patent drafters must thread this needle carefully, bearing in mind current trends in court decisions, the legislative landscape, and the specifics of each invention." - Rimon Law[3].

Highlight and Citation

"A patent with overly broad claims runs the risks of being invalidated. For an overly broad claim, two invalidation grounds are frequently used. One is the abstract idea exception and the other is failure to meet the written description requirement." - Rimon Law[3]

Key Takeaways

  • Claim Scope: The scope of claims must be carefully balanced to ensure they are not too broad or too narrow.
  • Prior Art: Thorough searches using tools like the USPTO's Patent Public Search and Global Dossier are essential.
  • Legal Framework: Claims must comply with the abstract idea exception and other legal requirements to avoid invalidation.
  • Practical Considerations: Budget, technical field, and client goals must be considered when drafting claims.
  • Validation: Patents with overly broad claims are more likely to be challenged and invalidated.

FAQs

Q: What is the importance of claim scope in a patent application? A: The claim scope defines the boundaries of what is protected under the patent. It must be balanced to avoid being too broad or too narrow to ensure validity and enforceability.

Q: How do court decisions impact patent claim drafting? A: Court decisions, such as the Alice decision, have shifted the legal framework, making it crucial to avoid overly broad claims that could be invalidated as abstract ideas.

Q: What tools are available for conducting thorough patent searches? A: Tools like the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are available for conducting thorough patent searches.

Q: Why are broader claims more difficult to get granted? A: Broader claims are more difficult to get granted because they are easier to invalidate due to the abstract idea exception and failure to meet the written description requirement.

Q: How does the client’s budget affect patent claim drafting? A: The client’s budget influences the scope of claims, as broader claims require more extensive prior art searches and can be more costly to obtain and maintain.

Sources

  1. U.S. Patent RE42,353 - Regulations.gov
  2. FI-111631-B1 - Unified Patents
  3. The Importance of Getting the Claim Scope Right in a US Patent Application - Rimon Law
  4. Search for patents - USPTO - USPTO
  5. European search report - googleapis.com

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,616,582

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,616,582

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9201095Jan 20, 1992
United Kingdom9213572Jun 26, 1992
United Kingdom9223735Nov 12, 1992

International Family Members for US Patent 5,616,582

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 130000 ⤷  Subscribe
Australia 3101093 ⤷  Subscribe
Australia 661533 ⤷  Subscribe
Canada 2086968 ⤷  Subscribe
Czech Republic 282038 ⤷  Subscribe
Czech Republic 9300043 ⤷  Subscribe
Germany 69300754 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.